TALS · Categories · Form 4
TALS - SEC Form 4 insider transactions
Talaris Therapeutics Inc. (TALS) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for TALS
- SEC Form 4 filed by Siegall Clay B4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- Thiara Parvinder was granted 75,782 shares (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- Srivastava Sapna was granted 518 shares (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Robinson Ryan F.4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- Middlekauff W Bradford was granted 69,201 shares (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- Mcdade Mark was granted 348,949 shares (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- Kulkarni Sandeep Chidambar was granted 716,085 shares (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- Kantoff Aaron was granted 37,891 shares (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- Jones Susan Dana was granted 22,934 shares (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- Johnson Kevin Bruce was granted 57,834 shares (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- Chyung Yung H. was granted 56,836 shares (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- Castelein Caley was granted 954,558 shares (SEC Form 4)4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Fenton Mary Kay4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Requadt Scott4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Srivastava Sapna4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Smith Karen L.4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Shah Gaurav4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Nader Francois4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Mcdade Mark4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Mackay Geoffrey4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Ildstad Suzanne4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Agarwala Sandip4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Ildstad Suzanne4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Ildstad Suzanne4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Ildstad Suzanne4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Ildstad Suzanne4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Ildstad Suzanne4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Ildstad Suzanne4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Ildstad Suzanne (Amendment)4/A - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Ildstad Suzanne (Amendment)4/A - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Ildstad Suzanne (Amendment)4/A - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Ildstad Suzanne (Amendment)4/A - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Ildstad Suzanne (Amendment)4/A - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Talaris Therapeutics Inc.4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4: Ildstad Suzanne sold $13,992 worth of shares (6,806 units at $2.06), decreasing direct ownership by 0.22% to 3,064,560 units4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4: Ildstad Suzanne sold $59 worth of shares (29 units at $2.05), decreasing direct ownership by 0.00% to 3,071,366 units4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4: Ildstad Suzanne sold $7,185 worth of shares (3,500 units at $2.05), decreasing direct ownership by 0.11% to 3,071,395 units4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4: Ildstad Suzanne sold $13,446 worth of shares (6,551 units at $2.05), decreasing direct ownership by 0.21% to 3,074,895 units4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Zdanowski Michael4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4: Requadt Scott was granted 4 shares, increasing direct ownership by 0.00% to 590,193 units4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Krieger Nancy4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Fenton Mary Kay4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4: Zdanowski Michael was granted 120,000 shares, increasing direct ownership by 8,163% to 121,470 units4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4: Requadt Scott was granted 80,000 shares, increasing direct ownership by 16% to 590,189 units4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4: Krieger Nancy was granted 80,000 shares, increasing direct ownership by 32% to 330,233 units4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4: Fenton Mary Kay was granted 80,000 shares, increasing direct ownership by 8,000% to 81,000 units4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4: Nader Francois disposed of 386,932 shares, acquired 386,932 shares and bought $500,020 worth of shares (138,500 units at $3.61) (Amendment)4/A - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4: Ildstad Suzanne sold $1,470,000 worth of shares (525,000 units at $2.80), decreasing direct ownership by 15% to 3,081,446 units4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4: Requadt Scott bought $167,374 worth of shares (39,382 units at $4.25), increasing direct ownership by 8% to 508,680 units4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4: Requadt Scott bought $36,571 worth of shares (8,618 units at $4.24), increasing direct ownership by 2% to 469,298 units4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4: Requadt Scott bought $35,412 worth of shares (9,444 units at $3.75), increasing direct ownership by 2% to 460,680 units4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Mcdade Mark4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Shah Gaurav4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Smith Karen L.4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Mackay Geoffrey4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Nader Francois4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Agarwala Sandip4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Srivastava Sapna4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4 filed by Smith Karen L.4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
- SEC Form 4: Ildstad Suzanne received a gift of 1,200,000 shares and gifted 1,200,000 shares, decreasing direct ownership by 25% to 3,606,446 units4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)